Two companies aiming to create an artificial “embryo” by merging the nucleus
of a human cell with a pig egg have abandoned their attempt to patent the
process after a Greenpeace exposé. “It was never our intention to claim
patents that would cover human embryos or human reproductive cloning,” says
Julia Greenstein of BioTransplant in Charlestown, Massachusetts. Both companies
deny the decision was in response to the Greenpeace campaign, but the pressure
group is claiming victory. “These are the first biotech companies to admit
having gone too far in claiming patents on human embryos,” it says in a press…
To continue reading, today with our introductory offers
Advertisement
More from ¿ìè¶ÌÊÓÆµ
Explore the latest news, articles and features
Popular articles
Trending ¿ìè¶ÌÊÓÆµ articles
1
The best new science-fiction books of June 2026
2
Does gravity create reality? A shocking path to a theory of everything
3
Photons behave very strangely if you try to cut them
4
How a radical new view of life could reveal its origin – and aliens
5
Pancreatic cancer halted by virus injection in three patients
6
Embryos made without sperm or eggs reveal why many pregnancies fail
7
Start-ups are racing to revolutionise mathematics with AI
8
Earliest use of anaesthetics uncovered in Chinese doctor’s tomb
9
3D-printed lymph nodes could widen access to CAR T-cell therapy
10
How autoimmune conditions can unexpectedly drive mental illness



